Dr Reddys Laboratories Q3 Results

  • BSE: 500124
  • NSE: DRREDDY
  • ISIN: INE089A01031
  • Sector: Biotechnology & Drugs
BSE
1,209-4.90 (-0.40%)
Volume92.17 K
Updated: Mon 25 Nov, 2024 | 15:53:03
NSE
1,209.3-5.15 (-0.42%)
Volume3.28 M
Updated: Mon 25 Nov, 2024 | 15:40:52
Today: 1,205.80
1,242.15
52-Wk: 1,074.35
1,420.20

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Dr Reddys Laboratories Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 7,236.806,902.60-%6,789.80-%
    Selling/ General/ Admin Expenses Total 3,026.702,885.80-%2,836.50-%
    Depreciation/ Amortization 373.50375.50-%323.70-%
    Total Operating Expense 5,587.205,171.40-%5,175.00-%
    Operating Income 1,649.601,731.20-%1,614.80-%
    Net Income Before Taxes 1,829.101,916.70-%1,637.70-%
    Net Income 1,380.901,482.20-%1,243.90-%
    Diluted Normalized EPS 83.3184.60-%75.37-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts